semaglutide manhattan beach Semaglutide: Weight-loss wonder drug sparks 'Ozempic Babies' phenomenon Gabriel Iglesias shared his experience

An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: a randomized controlled trial

CrossRef Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis Angelo Cignarelli, Valentina Annamaria Genchi, Giulia Le Grazie, Irene Caruso, Nicola Marrano, Giuseppina Biondi, Rossella DOria, Gian Pio Sorice, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola, Francesco Giorgino Frontiers in Endocrinology.2022;[Epub] CrossRef Sodiumglucose cotransporter 2 inhibitors do not increase the risk of fractures in realworld clinical practice in Korea: A national observational cohort study Kyoung Hwa Ha, Dae Jung Kim, Yong Jun Choi Journal of Diabetes Investigation.2022

it only reflects the biology of the GLP-1 system

The drugs prescribing information states that adults with a body mass index (BMI) of 30 or higher have obesity, while adults with a BMI of 27 or higher are considered overweight

For a full breakdown of how Mounjaro is approached in pregnancy, see our companion guide on Mounjaro in pregnancy

54 A nationwide cohort study of 120,054 patients with type 2 diabetes over a median follow up of 7.4 years found an 11% reduction in the rate of dementia with GLP-1 receptor agonists (95% of patients were on liraglutide) when used as a second-line treatment compared with other glucose-lowering therapies, with greater benefit seen with longer duration of use